Tag: Prescription Drugs
ASCO: Relugolix Superior to Leuprolide in Advanced Prostate Cancer
And, enzalutamide improves median overall survival in nonmetastatic, castration-resistant prostate cancer
Five-Day Course of Remdesivir Beneficial in Severe COVID-19
No significant difference seen in five-, 10-day course for severe COVID-19 without mechanical ventilation
Remdesivir Use Growing Globally in COVID-19 Patients
Yet, most physicians believe it is only moderately effective, better used earlier than official guidelines recommend
VA Slashes Use of Hydroxychloroquine to Treat COVID-19 Patients
Prescribing reduced to just three prescriptions in the last week as new research highlights possible dangers
Disease-Modifying Drug Regimen May Offer Benefit in Heart Failure
Lower risk for cardiovascular death or hospital admission seen in HF with reduced ejection fraction
CV Toxicity Tied to Azithromycin and/or Hydroxychloroquine
Risk increased for prolonged QT and/or ventricular tachycardia, including torsades de pointes
Benzodiazepines, Codispensed Opioids Common in Hemodialysis
Risk for mortality increased for those receiving short-acting benzodiazepines alone or with opioids
Remdesivir Beats Placebo for Time to COVID-19 Recovery
Researchers suggest antiviral agents in combination with other therapeutic approaches may further improve outcomes
WHO Suspends Testing of Hydroxychloroquine in COVID-19 Patients
In light of recent findings, hydroxychloroquine arm of WHO global study paused temporarily
Hydroxychloroquine Plus Macrolides No Benefit in COVID-19
Hydroxychloroquine, chloroquine with or without macrolides linked to in-hospital mortality, arrhythmia
